
Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) (BIOVF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOVF · as of Jun 9, 2026
Key Statistics
Explore Swedish Orphan Biovitrum AB (publ) Data
biovf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
biovf competitorsStock Performance
Full HistoryAbout Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) Operating under the ticker BIOVF, Swedish Orphan Biovitrum AB (publ) is a specialized biotechnology company dedicated to the research, development, manufacturing, and commercialization of pharmaceutic…
what is swedish orphan biovitrum ab (publ) · biovf stock overview · swedish orphan biovitrum ab (publ) company profile · who is swedish orphan biovitrum ab (publ) ceo · biovf OTC · swedish orphan biovitrum ab (publ) headquarters · swedish orphan biovitrum ab (publ) business segments
About Stock Overview & Key Data
Swedish Orphan Biovitrum AB (publ) (BIOVF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 8, 2021. As of the latest trading session, BIOVF stock price is $47.35, with a market capitalization of $16.4B. The stock has returned +48.02% over the past 12 months and +34.33% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Swedish Orphan Biovitrum AB (publ) stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Swedish Orphan Biovitrum AB (publ) reported revenue of $28.2B and net income of $476.8M. For detailed data — including Swedish Orphan Biovitrum AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Swedish Orphan Biovitrum AB (publ) (BIOVF) stock price is $47.35. The stock is traded on OTC under the ticker symbol BIOVF. The 52-week range is $27.06 – $48.00.